Pfizer Stock News

UPDATED: December 13, 2021, 00:11 AM THE Department of Health (DoH) reported 402 new cases of Covid-19 on Sunday. This pushed total cases to 2,836,592 of which only 11,255 or 0.4 percent are active. The DoH said 5,210 of the active cases were mild and asymptomatic, while 3,683 were moderate, 1,961 severe, and 401 critical. There were 509 new recoveries, bringing the total to 2,775,057. The positivity rate remained low at 1.2 percent after 36,799 tests were conducted. Deaths from Covid-19 reached 50,280 after 184 new fatalities were reported. DoH noted that only six of the deaths occurred this December. The highest number of deaths was 73 in October, followed by 54 in September. Hospital bed utilization at the national level is at 23 percent each for intensive care units (ICU) and isolation beds, and 13 percent for ward beds. In the National Capital Region, the utilization rate is slightly higher, with 26 percent for ICU, 19 percent for isolation, and 18 percent for wards. In a related development, Food and Drug Authority (FDA) Director General Eric Domingo confirmed to The Manila Times that vaccine manufacturer Pfizer has submitted an application for emergency use authorization (EUA) of its Covid-19 vaccine for children 5 to 11 years old.

Legacy Financial Advisors Inc. lifted its stake in shares of Pfizer Inc. (NYSE:PFE) by 15.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 37,603 shares of the biopharmaceutical companys stock after purchasing an additional 5,050 shares during the quarter. Pfizer accounts for about []

Community Trust & Investment Co. boosted its stake in Pfizer Inc. (NYSE:PFE) by 186.0% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 63,212 shares of the biopharmaceutical companys stock after buying an additional 41,111 shares during the quarter. Community Trust & Investment Co.s []

Community Trust & Investment Co. lifted its position in shares of Pfizer Inc. (NYSE:PFE) by 186.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,212 shares of the biopharmaceutical companys stock after acquiring an additional 41,111 shares during the quarter. Community Trust []

Security Asset Management lessened its position in shares of Pfizer Inc. (NYSE:PFE) by 6.6% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 21,238 shares of the biopharmaceutical companys stock after selling 1,500 shares during the quarter. Security Asset Managements holdings in Pfizer were worth []

BOOSTER jabs are being made available for every eligible Brit over the age of 18 in the hope they will curb the rapid rise of Omicron infections in the UK. How effective are booster jabs against Omicron? Read more here Daily Express :: Health Feed Is the booster effective against Omicron? Pfizer, AstraZeneca, Moderna latest insight

A third dose of Pfizer''s COVID-19 vaccine provides "significant protection" against the Omicron variant of COVID-19, Israel researchers said Saturday.

All Global Research articles can be read in 51 languages by activating the Translate Website drop down menu on the top banner of our home page (Desktop version). To receive Global Researchs Daily Newsletter (selected articles), click here . Visit The post Why Did Pfizer Refuse to Distribute the Vaccine in Countries Which Didnt Grant Indemnity? appeared first on Global Research .

Global Macro / Markets / Investing: African countries are relaxing visa rules for each other ahead of a historic free trade deal. QZ Big Pharmas Offshore Fraud Strategy. Fascinating read on how Pfizer bribed doctors, hospital administrators and government officials all over the world Forbes A huge study of 20 years of global

Let’s dive right in! Adam Grant , an organizational psychologist, writes for The New York Times that we are now living through a “boring apocalypse.” In a poll of Americans conducted from Dec. 3 to Dec. 6, almost all — 94 percent — had heard of Omicron. Despite questions that remain unanswered about Omicron’s risks and whether it can evade vaccines, only 23 percent said they were likely to cancel their holiday plans, and 28 percent said they were likely to stop gathering with others outside their households. It’s a stark difference from when the pandemic first started. Back then, as we learned of this new highly contagious and deadly disease with no vaccine or treatment, many of us stocked up on food and toilet paper, started wiping down our groceries and went into lockdown, only venturing out with protective gear. But many people aren’t so afraid of Covid-19 anymore, complicating public health authorities’ efforts to slow Omicron’s spread. We’ve all seen this horror movie before, and when you’ve watched the killer jump out brandishing a weapon 10 times — even when you’ve watched him kill — it just doesn’t freak you out the same way.

The booster dose protects about a hundred times better, the researchers say.

The CEO of Pfizer Albert Bourla declared last week that a fourth covid shot would be needed sooner than expected to protect against the Omicron variant. His announcement comes despite the fact that no deaths [] The post Pfizer CEO Says A Fourth Covid Jab Will Be Needed Sooner Than Expected appeared first on News Punch .

NEW DELHI, Dec. 12 (Xinhua) -- India reported two more cases of the Omicron variant (B.1.1.529) on Sunday, taking the country''s tally of the new variant to 35, officials said. One case was reported in Chandigarh, where a 20-year-old man arriving from Italy on Nov. 22 was diagnosed with COVID-19 on Dec. 1, according to local health officials. He has been fully vaccinated with the Pfizer vaccine. The case i

Dr Michael Girouard, whose wife Dr Jonie Girouard was caught giving out medical exemptions for the Pfizer vaccine, is also now under scrutiny.

Australians will now be able to receive a Moderna or a Pfizer booster shot five months after their last vaccination after new evidence showing immunity to the Omicron variant waning six months after a second dose.